» Articles » PMID: 18309045

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP-43 and ALS.

Citing Articles

Mechanisms underlining R-loop biology and implications for human disease.

Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.

PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.


Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases.

Blair K, Martinez-Serra R, Gosset P, Martin-Guerrero S, Morotz G, Atherton J Acta Neuropathol Commun. 2025; 13(1):49.

PMID: 40045432 PMC: 11881430. DOI: 10.1186/s40478-025-01964-7.


Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis.

Mengistu D, Terribili M, Pellacani C, Ciapponi L, Marzullo M Front Mol Med. 2025; 5:1530719.

PMID: 40017539 PMC: 11865237. DOI: 10.3389/fmmed.2025.1530719.


TMEM106B deficiency leads to alterations in lipid metabolism and obesity in the TDP-43 knock-in mouse model.

Yang C, Lee G, Hao L, Hu F Commun Biol. 2025; 8(1):315.

PMID: 40011708 PMC: 11865606. DOI: 10.1038/s42003-025-07752-2.


Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects.

Ruffo P, Traynor B, Conforti F J Neurol. 2025; 272(3):233.

PMID: 40009238 PMC: 11865122. DOI: 10.1007/s00415-025-12975-8.


References
1.
Mishra M, Paunesku T, Woloschak G, Siddique T, Zhu L, Lin S . Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol. 2007; 114(1):81-94. DOI: 10.1007/s00401-007-0240-7. View

2.
Rollinson S, Snowden J, Neary D, Morrison K, Mann D, Pickering-Brown S . TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett. 2007; 419(1):1-4. DOI: 10.1016/j.neulet.2007.03.044. View

3.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

4.
Buratti E, Baralle F . Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 2007; 13:867-78. DOI: 10.2741/2727. View

5.
Schumacher A, Friedrich P, Diehl-Schmid J, Ibach B, Eisele T, Laws S . No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiol Aging. 2006; 28(11):1789-90. DOI: 10.1016/j.neurobiolaging.2006.07.016. View